Trial · NCT03904693
Adverse event totals24
The totals the trial posted for each group.
1 to 20 of 24
Download this page as JSON| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | DB: Treatment-naive and Prior ERA Strata: Macitentan Monotherapy 10 Milligrams (mg) | 0 | 35 |
| Total, all-cause mortality | DB: Treatment-naive And Prior ERA Strata: M/T FDC | 2 | 71 |
| Total, all-cause mortality | DB: Treatment-naive And Prior PDE-5i Strata: Tadalafil Monotherapy 20 mg (2 Tablets*20 mg) | 0 | 44 |
| Total, all-cause mortality | DB: Treatment-naive And Prior PDE-5i Strata: M/T FDC | 2 | 87 |
| Total, all-cause mortality | DB: Treatment-naive and Prior ERA/ PDE-5i Strata: M/T FDC | 3 | 108 |
| Total, all-cause mortality | OL: Treatment-naive and Prior ERA Strata: M/T FDC | 0 | 35 |
| Total, all-cause mortality | OL: Treatment-naive and Prior PDE-5i Strata: M/T FDC | 2 | 43 |
| Total, all-cause mortality | DB + OL: Treatment-naive and Prior ERA/ PDE-5i Strata: M/T FDC | 9 | 107 |
| Total, other adverse events | DB: Treatment-naive and Prior ERA Strata: Macitentan Monotherapy 10 Milligrams (mg) | 16 | 35 |
| Total, other adverse events | DB: Treatment-naive And Prior ERA Strata: M/T FDC | 49 | 70 |
| Total, other adverse events | DB: Treatment-naive And Prior PDE-5i Strata: Tadalafil Monotherapy 20 mg (2 Tablets*20 mg) | 31 | 44 |
| Total, other adverse events | DB: Treatment-naive And Prior PDE-5i Strata: M/T FDC | 58 | 86 |
| Total, other adverse events | DB: Treatment-naive and Prior ERA/ PDE-5i Strata: M/T FDC | 72 | 107 |
| Total, other adverse events | OL: Treatment-naive and Prior ERA Strata: M/T FDC | 28 | 35 |
| Total, other adverse events | OL: Treatment-naive and Prior PDE-5i Strata: M/T FDC | 38 | 43 |
| Total, other adverse events | DB + OL: Treatment-naive and Prior ERA/ PDE-5i Strata: M/T FDC | 89 | 107 |
| Total, serious adverse events | DB: Treatment-naive and Prior ERA Strata: Macitentan Monotherapy 10 Milligrams (mg) | 3 | 35 |
| Total, serious adverse events | DB: Treatment-naive And Prior ERA Strata: M/T FDC | 11 | 70 |
| Total, serious adverse events | DB: Treatment-naive And Prior PDE-5i Strata: Tadalafil Monotherapy 20 mg (2 Tablets*20 mg) | 4 | 44 |
| Total, serious adverse events | DB: Treatment-naive And Prior PDE-5i Strata: M/T FDC | 12 | 86 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03904693/event-totals